|
시장보고서
상품코드
2050974
3세대 시퀀싱 시장 : 기술별, 컴포넌트별, 용도별, 최종사용자별, 지역별Third Generation Sequencing Market, By Type of Technology, By Component, By Application, By End-User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
3세대 시퀀싱 시장은 2026년에 10억 6,910만 달러로 추정되고, 2033년까지 41억 3,100만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 21.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 10억 6,910만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 21.30% | 2033년 시장 규모 예측 : | 41억 3,100만 달러 |
3세대 시퀀싱(롱리드 시퀀싱이라고도 함)은 DNA 시퀀싱 기법의 일종입니다. 3세대 시퀀싱은 단일 분자 수준에서 뉴클레오티드 서열을 읽는 방식으로 작동하며, 기존 방식보다 훨씬 더 긴 리드를 생성할 수 있습니다. 3세대 시퀀싱으로 알려진 2세대 시퀀싱보다 더 긴 리드를 생성할 수 있는 능력을 가지고 있습니다. 또한, 3세대 시퀀싱은 cDNA 시퀀싱의 '골드 스탠다드' 기술로 부상하고 있습니다.
시장 역학
만성질환 및 감염성 질환의 유병률 증가, 임상 진단에서의 활용 확대, 유전체학의 적용 확대, 신약개발에 대한 관심 증가, 기존 기술 대비 효율성 향상 등이 세계 3세대 시퀀싱 시장의 성장을 견인할 것으로 예상되는 주요 요인으로 꼽힙니다.
예를 들어, 만성질환의 부담이 증가함에 따라 3세대 시퀀싱 기술 기반 장비의 이용과 수요도 빠르게 증가하고 있습니다. TGS 기술은 만성질환의 분자 메커니즘을 규명하는 데 도움이 되기 때문에 그 유전자 발현 연구에 활용될 수 있습니다. 세계보건기구(WHO)의 2023년 9월 보고서에 따르면, 비감염성 질환(NCD)은 매년 4,100만 명의 목숨을 앗아가고 있으며, 이는 전 세계 전체 사망자의 74%에 해당합니다. NCD로 인한 사망의 대부분은 심혈관 질환으로 연간 1,790만 명에 달할 전망입니다. 이어 암(930만 명), 만성 호흡기 질환(410만 명), 당뇨병(200만 명)이 뒤를 이었습니다.
또한, 미국 질병예방통제센터(CDC)에 따르면 심장병, 암, 당뇨병과 같은 만성질환은 미국 내 사망 및 장애의 주요 원인으로 꼽히고 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업의 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 3세대 시퀀싱 시장의 주요 업체를 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 3세대 시퀀싱 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 3세대 시퀀싱 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 3세대 시퀀싱 시장 : 기술별, 2026년-2033년
제5장 3세대 시퀀싱 시장 : 컴포넌트별, 2026년-2033년
제6장 3세대 시퀀싱 시장 : 용도별, 2026년-2033년
제7장 3세대 시퀀싱 시장 : 최종사용자별, 2026년-2033년
제8장 3세대 시퀀싱 시장 : 지역별, 2026년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.15Third Generation Sequencing Market is estimated to be valued at USD 1069.1 Mn in 2026 and is expected to reach USD 4,131.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 21.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1069.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 21.30% | 2033 Value Projection: | USD 4,131 Mn |
Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the 'gold-standard' technology for cDNA sequencing.
Market Dynamics
Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.
For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. TGS technologies can be utilized in studying gene expression of chronic diseases as it help in understanding their molecular mechanisms. According to the World Health Organization (WHO), September 2023 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).
Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include PacBio , Oxford Nanopore Technologies, Ltd., BGI Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC Biotech AG, and Phase Genomics, Inc., among others
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.
Market Segmentation
- By Technology (Revenue, USD Mn, 2021 - 2033)
- Single-Molecule Real-Time (SMRT) Sequencing
- Nanopore Sequencing
- Synthetic long-read sequencing
- By Component (Revenue, USD Mn, 2021 - 2033)
- Products
- Services
- By (Revenue, USD Mn, 2021 - 2033) Application
- Genome Sequencing
- Epigenetics
- Transcriptomics
- Metagenomics
- Others
- By End-user (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical companies
- Hospitals and clinics
- Contract research organizations (CROs)
- Others (Academic and research institutes)
- By Geography (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- PacBio
- Oxford Nanopore Technologies, Ltd.
- BGI Genomics Co., Ltd.
- F.Hoffmann-La Roche AG
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- GenapSys Inc.
- Loop Genomics
- Nabsys, Inc.
- Genia Technologies, Inc.
- Stratos Genomics, Inc.
- GATC Biotech AG
- Phase Genomics, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Third Generation Sequencing, By Type of Technology
- Market Third Generation Sequencing, By Component
- Market Third Generation Sequencing, By Application
- Market Third Generation Sequencing, By End User
- Market Third Generation Sequencing, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing Demand for Precision Medicine
- High Cost & Technical Challenges
- Increasing Adoption of TGS Platforms
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Third Generation Sequencing Market, By Technology, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Single-molecule real-time (SMRT) sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Nanopore Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Synthetic long-read sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
5. Third Generation Sequencing Market, By Component, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Instruments
- Reagents and consumables
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
6. Third Generation Sequencing Market, By Application, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Genome Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Epigenetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Transcriptomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Metagenomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
7. Third Generation Sequencing Market, By End User, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Contract research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033,(US$ Mn)
8. Third Generation Sequencing Market, By Geography, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 - 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- PacBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Nanopore Technologies, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenapSys Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Loop Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nabsys, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genia Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stratos Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GATC Biotech AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phase Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
